CA2100836E - Composition pharmaceutique - Google Patents
Composition pharmaceutiqueInfo
- Publication number
- CA2100836E CA2100836E CA2100836 CA2100836E CA 2100836 E CA2100836 E CA 2100836E CA 2100836 CA2100836 CA 2100836 CA 2100836 E CA2100836 E CA 2100836E
- Authority
- CA
- Canada
- Prior art keywords
- composition
- stearic acid
- weight
- pharmaceutical composition
- ticlopidine hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 17
- MTKNGOHFNXIVOS-UHFFFAOYSA-N ticlopidine hydrochloride Chemical compound [H+].[Cl-].ClC1=CC=CC=C1CN1CC(C=CS2)=C2CC1 MTKNGOHFNXIVOS-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 26
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 26
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000008117 stearic acid Substances 0.000 claims abstract description 26
- 229960002961 ticlopidine hydrochloride Drugs 0.000 claims abstract description 24
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 22
- 150000007524 organic acids Chemical class 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 38
- 239000011230 binding agent Substances 0.000 claims description 19
- 239000007884 disintegrant Substances 0.000 claims description 16
- 239000000314 lubricant Substances 0.000 claims description 13
- 239000003085 diluting agent Substances 0.000 claims description 12
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 7
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 7
- 229960001681 croscarmellose sodium Drugs 0.000 claims description 7
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 7
- 239000003381 stabilizer Substances 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims 8
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229940028869 ticlid Drugs 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005550 wet granulation Methods 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 238000009491 slugging Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2100836E true CA2100836E (fr) | 1998-02-03 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6333332B1 (en) | Stabilized pharmaceutical compositions containing bupropion hydrochloride | |
| US4834965A (en) | Controlled release pharmaceutical composition | |
| US5972381A (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| US5635209A (en) | Stabilized composition of levothyroxine sodium medication and method for its production | |
| AU614710B2 (en) | Stabilized drug compositions | |
| US20060106057A1 (en) | Stabilization of quinapril using magnesium oxide | |
| SK284655B6 (sk) | Farmaceutický prostriedok vo forme kapsuly alebo lisovanej tablety obsahujúci efavirenz a spôsob jeho výroby | |
| HU226619B1 (en) | Process of making dosage units containing at least one progestogen by wet granulation | |
| EP0954288B1 (fr) | Solution solide d'un agent antifongique avec biodisponibilite amelioree | |
| US20020123503A1 (en) | Cabergoline pharmaceutical compositions and methods of use thereof | |
| KR920006908B1 (ko) | 디히드로피리딘을 함유하는 고상 약제의 제조 방법 | |
| US5520928A (en) | Pharmaceutical composition of ticlopidine hydrochloride | |
| US5114948A (en) | Stabilized pergolide compositions | |
| KR101197277B1 (ko) | 경구용 결핵의 치료용 또는 예방용 고형 제형 | |
| FI96480B (fi) | Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi | |
| US5266581A (en) | Solid composition containing dihydropyridine, PVP and PVPP | |
| US5785995A (en) | Pharmaceutical tablet of amiodarone salt | |
| KR100590622B1 (ko) | 레보시멘단과 알긴산을 포함하는 안정한 조성물 | |
| US5512298A (en) | Cytarabine ocfosfate hard capsule | |
| US20080008751A1 (en) | Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof | |
| BG61242B2 (bg) | Твърд фармацевтичен състав за орална употреба на база дапипразол | |
| JP4591726B2 (ja) | メキタジン含有内服固形製剤 | |
| EP2364138A2 (fr) | Formulation de palonosétron | |
| WO2000001364A1 (fr) | Compositions pharmaceutiques stables de derives de thieno [2,3-c] pyridine | |
| US11969413B2 (en) | Pharmaceutical compositions of deutetrabenazine and process for preparation thereof |